Claris Lifesciences
Claris Lifesciences is an Indian pharmaceutical company that manufactures and markets a broad range of injectable drugs and related products for global markets. Its portfolio covers anesthesia and analgesics, blood products, anti-infectives, critical care, nephrology, infusion therapy and nutrition, with products delivered in vials, ampoules, glass bottles and various bag formats. The company operates through Claris Injectables and Claris Otsuka, a joint venture with Otsuka Pharmaceutical Factory and Mitsui & Co. for infusion business in India and emerging markets. It serves government and private hospitals, aid agencies and nursing homes, focusing on generic, technology-driven injectables and related systems, solutions, medicines, disposables and equipment. It also provides dialysis and transplant products and supports multiple delivery systems to meet critical-care needs.
Top Regions
Top Stages
1 past transactions
CoMentis
Series D in 2008
CoMentis, Inc. is a biotechnology company dedicated to the research, discovery, and development of small-molecule drugs aimed at treating neurovascular diseases, particularly Alzheimer's disease and schizophrenia. The company is focused on creating nicotinic acetylcholine receptor modulators to address cognitive disorders. Founded in 2004 as Athenagen, Inc., it underwent a name change to CoMentis in February 2007 after merging with Zapaq, Inc., which strengthened its position in the neurovascular disease sector. CoMentis is headquartered in South San Francisco, California.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.